Low-dose B Vitamins Supplementation Ameliorates Cardiovascular Risk: a Double-blind Randomized Controlled Trial in Healthy Chinese Elderly
Overview
Affiliations
Purpose: We investigated whether daily supplementation with low-dose B vitamins in the healthy elderly population improves the Framingham risk score (FRS), a predictor of cardiovascular disease risk.
Methods: Between 2007 and 2012, a double-blind randomized controlled trial was conducted in a rural area of North China. In all, 390 healthy participants aged 60-74 were randomly allocated to receive daily vitamin C (50 mg; control group) or vitamin C plus B vitamins (400 µg folic acid, 2 mg B6, and 10 µg B12; treatment group) for 12 months. FRSs were calculated for all 390 subjects.
Results: Folate and vitamin B12 plasma concentrations in the treatment group increased by 253 and 80%, respectively, after 6 months, stopped increasing with continued supplementation after 12 months and returned to baseline levels 6 months after supplementation cessation. Compared with the control group, there was no significant effect of B vitamin supplementation on FRSs after 6 months (mean difference -0.38; 95% CI -1.06, 0.31; p = 0.279), whereas a significant effect of supplementation was evident after 12 months (reduced magnitude 7.6%; -0.77; 95% CI -1.47, -0.06; p = 0.033). However, this reduction disappeared 6 months after supplementation stopped (-0.07; 95% CI -0.80, 0.66; p = 0.855). The reduction in FRS 12 months after supplementation was more pronounced in individuals with a folate deficiency (10.4%; -1.30; 95% CI -2.54, -0.07; p = 0.039) than in those without (4.1%; -0.38; 95% CI -1.12, 0.36; p = 0.313). B vitamins increased high-density lipoprotein cholesterol by 3.4% after 6 months (0.04; 95% CI -0.02, 0.10; p = 0.155) and by 9.2% after 12 months (0.11; 95 % CI 0.04, 0.18; p = 0.003). Compared with the control group, this change in magnitude decreased to 3.3% (0.04; 95 % CI -0.02, 0.10; p = 0.194) 6 months after supplementation cessation.
Conclusions: Daily supplementation with a low-dose of B vitamins for 12 months reduced FRS, particularly in healthy elderly subjects with a folate deficiency. These reduced effects declined after supplementation cessation, indicating a need for persistent supplementation to maintain the associated benefits.
Wang J, Zhao Y, Chen Z, Huang R Front Pharmacol. 2025; 15():1451713.
PMID: 39845792 PMC: 11751046. DOI: 10.3389/fphar.2024.1451713.
Zamani M, Rezaiian F, Saadati S, Naseri K, Ashtary-Larky D, Yousefi M Nutr J. 2023; 22(1):12.
PMID: 36829207 PMC: 9951414. DOI: 10.1186/s12937-023-00843-y.
Lu X, Wang Y, Mo Q, Huang B, Wang Y, Huang Z Eur J Nutr. 2023; 62(4):1599-1610.
PMID: 36717385 PMC: 9886420. DOI: 10.1007/s00394-023-03087-y.
Folate, Vitamin B6, and Vitamin B12 Status in Association With Metabolic Syndrome Incidence.
Zhu J, Chen C, Lu L, Shikany J, DAlton M, Kahe K JAMA Netw Open. 2023; 6(1):e2250621.
PMID: 36630134 PMC: 9856626. DOI: 10.1001/jamanetworkopen.2022.50621.
Zhang D, Li Y, Lang X, Zhang Y J Clin Endocrinol Metab. 2022; 107(10):2822-2832.
PMID: 35907182 PMC: 9516105. DOI: 10.1210/clinem/dgac429.